The U.S. Department of Human Health Services (HHS) released its National Influenza Vaccine Modernization Strategy (NIVMS) 2020–2030, as directed by Executive Order (EO) 13887, on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health. The strategy outlines a vision for the United States’ influenza vaccine enterprise to be highly responsive, flexible, resilient, scalable, and more effective at reducing the impact of seasonal and pandemic influenza viruses. This vision is supported by three overarching strategic objectives:
- Strengthen and diversify influenza vaccine development, manufacturing, and supply chain;
- Promote innovative approaches and use of new technologies to detect, prevent, and respond to influenza; and
- Increase influenza vaccine access and coverage across all populations.
These strategic objectives aim to systematically transform the United States’ influenza vaccine enterprise. Execution of this strategic approach over the next ten years will require innovative partnerships, financial investments, and efficient utilization of resources.
